BBLG
Bone Biologics Corp
NASDAQ: BBLG · HEALTHCARE · BIOTECHNOLOGY
$1.31
+0.38% today
Updated 2026-04-30
Market cap
$2.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.65
Dividend yield
—
52W range
$1 – $7
Volume
0.0M
Bone Biologics Corp (BBLG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-5.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+78.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-4.3%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.63 | -85.3% | $1.52 | $1.54 | +1.3% |
| 2025-11-14 | $-0.37 | +95.3% | $1.70 | $1.63 | -4.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.34 | $-0.63 | -85.3% | — | — |
| 2025-09-30 | $-7.92 | $-0.37 | +95.3% | — | — |
| 2025-06-30 | $-0.58 | $-1.33 | -129.3% | — | — |
| 2025-03-31 | $-7.68 | $-0.32 | +95.8% | — | — |
| 2024-12-31 | $-3.90 | $-2.88 | +26.2% | — | — |
| 2024-09-30 | $-3.60 | $-14.22 | -295.0% | — | — |
| 2024-06-30 | $-1.39 | $-0.67 | +51.8% | — | — |
| 2024-03-31 | $-7.60 | $-1.31 | +82.8% | — | — |
| 2023-12-31 | $-5.60 | $-2.47 | +55.9% | — | — |
| 2023-09-30 | $-3.04 | $-0.61 | +79.9% | — | — |
| 2023-06-30 | $-1.50 | $-0.48 | +68.0% | — | — |
| 2023-03-31 | $-2.10 | $-6.90 | -228.6% | — | — |
Frequently asked questions
Has Bone Biologics Corp beaten earnings estimates?
Bone Biologics Corp has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -5.9% over the last 4 quarters.
How does BBLG stock react to earnings?
BBLG stock has moved an average of -1.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.